Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q2- Text added to 2023 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
accredited, Additionally, announce, announced, caution, chain, commodity, conflict, demonstrate, demonstrated, disagree, dose, escalation, exceeding, exploitation, Food, fully, geopolitical, harm, harmed, heavily, instability, interpret, Investigational, Israel, Klybeckstrasse, long, lung, magnify, multicenter, neuroendocrine, neurological, opportunity, payment, pharmacodynamic, pharmacokinetic, Phase, preliminary, prolonged, publish, published, reached, responsibility, Roche, short, study, tiered, tolerability, topline, typically, Ukraine, ultimately, upfront, verification, viewed, volatility, warrant, weigh, worsen
Removed:
Hochbergerstrasse
Valuein 2023 Q2 filing- Value in 2023 Q3 filing
Original filings
Filing view